Beckerman William E, Tadros Rami O, Faries Peter L, Torres Marielle, Wengerter Sean P, Vouyouka Ageliki G, Lookstein Robert A, Marin Michael L
Division of Vascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
Division of Vascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
J Vasc Surg. 2016 Jul;64(1):63-74.e2. doi: 10.1016/j.jvs.2016.01.034. Epub 2016 Mar 23.
Studies have shown that a sizable percentage of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) is performed outside the instructions for use (IFU). We report our long-term outcomes after EVAR with respect to device-specific IFU.
Computed tomography angiography data from a cohort of 566 patients meeting inclusion criteria who underwent elective EVAR between 2003 and 2014 were examined. Preoperative anatomic measurements for each patient were taken and compared with device-specific IFU. Primary outcomes included all-cause mortality and AAA-related mortality. Secondary outcomes were late-onset rupture, need for reintervention, endoleaks, aneurysm sac enlargement, and intraoperative and perioperative complications.
Nine different stent grafts were placed in this set of patients with a mean follow-up of 3.54 ± 2.65 years. Most patients (465; 82.2%) were male, and the mean age was 74.8 ± 8.70 years. Overall, 176 patients (31.1%) fit all IFU anatomic criteria, and 535 patients (94.5%) fit at least half of IFU criteria. In patients, iliac artery diameter was most commonly outside of IFU (253; 44.7%). A total of 1114 iliac arteries were treated, with 463 (41.6%) treated outside of iliac artery diameter IFU; the majority of these (374; 80.7%) were larger than IFU. Demographics and comorbidities were comparable between the groups within and outside of IFU. AAA-related mortality and all-cause mortality were similar between these two groups, as was late-onset rupture, need for reintervention, rates of endoleak, aneurysm sac enlargement, and major intraoperative and perioperative complications. The sole statistically significant difference in secondary outcomes was increased perioperative blood transfusion needed in those treated outside the IFU, 13.2% vs 6.2% in those treated within IFU (P = .02); however, this was not associated with decreased access vessel diameter or iliac artery rupture.
Despite most EVAR patients being treated outside of IFU, there was no difference in outcomes with respect to all-cause mortality or aneurysm-related mortality. In addition, with the exception of perioperative blood transfusions, there was no association between IFU adherence and late-onset rupture, need for reintervention, rates of endoleak, aneurysm sac enlargement, or most other major complications.
研究表明,相当大比例的腹主动脉瘤(AAA)血管内动脉瘤修复术(EVAR)是在使用说明(IFU)之外进行的。我们报告了根据特定器械IFU进行EVAR后的长期结果。
检查了2003年至2014年间接受择期EVAR且符合纳入标准的566例患者的计算机断层扫描血管造影数据。对每位患者进行术前解剖测量,并与特定器械的IFU进行比较。主要结局包括全因死亡率和与AAA相关的死亡率。次要结局为迟发性破裂、再次干预的需求、内漏、动脉瘤囊扩大以及术中和围手术期并发症。
在这组患者中放置了9种不同的支架移植物,平均随访时间为3.54±2.65年。大多数患者(465例;82.2%)为男性,平均年龄为74.8±8.70岁。总体而言,176例患者(31.1%)符合所有IFU解剖标准,535例患者(94.5%)至少符合一半的IFU标准。在患者中,髂动脉直径最常超出IFU范围(253例;44.7%)。共治疗了1114条髂动脉,其中463条(41.6%)在髂动脉直径IFU之外进行治疗;其中大多数(374条;80.7%)大于IFU标准。IFU范围内外的组间人口统计学和合并症具有可比性。这两组之间与AAA相关的死亡率和全因死亡率相似,迟发性破裂、再次干预的需求、内漏发生率、动脉瘤囊扩大以及主要术中和围手术期并发症也相似。次要结局中唯一具有统计学意义的差异是IFU范围外治疗的患者围手术期输血需求增加,IFU范围内治疗的患者为13.2%,IFU范围外治疗的患者为6.2%(P = 0.02);然而,这与入路血管直径减小或髂动脉破裂无关。
尽管大多数接受EVAR的患者是在IFU之外接受治疗的,但在全因死亡率或与动脉瘤相关的死亡率方面,结局并无差异。此外,除了围手术期输血外,IFU依从性与迟发性破裂、再次干预的需求、内漏发生率、动脉瘤囊扩大或大多数其他主要并发症之间没有关联。